Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Health Care Ads Leave Washington, Follow Lawmakers Home During Break
Roll Call reports that "several major industry stakeholders" will be "noticeably absent from the advertising airwaves over the July Fourth recess. Though they will continue to keep in touch with Members through meetings and grass roots, AARP, the American Medical Association, America"s Health Insurance Plans, the Federation of American Hospitals and AdvaMed all say they are sitting out this recess when it comes to advertising campaigns." Senate Finance Chairman Max Baucus, D-Mont., and White House aides have "warned that any groups that run ads attacking reform efforts before the bills have been crafted would lose their seats at the bargaining table," but the "advocacy ad floodgates" may "open shortly." Until then, "groups are working in a lower-profile way to get their messages across to Members," such as planning in-district meetings with Members and activating grassroots networks.

PolyMedix Receives United States Patent For Angiogenesis Inhibitor Compounds
PolyMedix, Inc. (OTCBB: PYMX), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, announced that the United States Patent and Trademark Office issued a patent assigned to PolyMedix relating to angiogenesis inhibitors. The patent, number 7,553,876, entitled "Polycationic Compounds and Uses Thereof," relates to therapeutic uses of PolyMedix compounds for inhibiting angiogenesis.
News of the day
SAMe Is Effective In Preventing Formation Of Primary Liver Cancer In Rats
A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer. SAMe, a widely available nutritional supplement, with little known side effects, was found to be effective in preventing the formation of HCC in rats. However, high enough levels of SAMe were not attainable to successfully treat established HCC. The findings are available in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases.
Nutrition

New 'H1N1 Flu Re Centre' Available On TheLancet.com

The Lancet has partnered with over 40 Elsevier-published journals and 11 learned societies to launch a new H1N1 Flu Re Centre for healthcare professionals at TheLancet.com. Developed byThe Lancet editors, this new online information clearinghouse aggregates infectious disease and public health information from across Elsevier"s spectrum of content. To upgrade the level of expert analysis and advice on the prevention, detection, diagnosis, and treatment of the influenza A H1N1 (swine flu), The Lancet, the respected international medical journal, today announced the launch of its H1N1 Flu Re Centre , a complimentary microsite for physicians, nurses, pharmacists, and healthcare professionals across the globe. Among the many H1N1-related websites, TheLancet.com"s H1N1 Flu Re Centre offers an unparalleled scope and depth of content. "The H1N1 Flu Re Centre fulfills The Lancet"s mission of improving outcomes in health and in the business of health," said Richard Horton, Editor-in-Chief of The Lancet journals. "Healthcare professionals will have immediate access to timely, accurate information aggregated from diverse online res and journals. The global medical community will benefit from this re." Led by John McConnell, Editor of The Lancet Infectious Diseases, the editorial team has scanned thousands of journals published by Elsevier for articles on the scientific, clinical, and public health aspects of the H1N1 virus. Articles selected by The Lancet editors have been categorised into relevant topics and full-text PDFs made available for free download from the H1N1 Re Centre. John McConnell added: "We are especially grateful to our society partners for allowing us to host their content at TheLancet.com and for making this freely available to all visitors to the H1N1 Re Centre." Late-breaker session In partnership with the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), The Lancet will co-host on Sunday, May 17 a late-breaker session on influenza A H1N1 at the European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) in Helsinki, Finland. Over 6,500 delegates from around the globe are pre-registered for the ECCMID meeting. Speakers at the session are Albert Osterhaus (Rotterdam, Netherlands) and Javier Garau (Barcelona, Spain). Video highlights from the session will be available next week from The Lancet"s H1N1 Flu re Centre. Conference On August 21-23, 2009, The Lancet is holding a conference in Qingdao, China, on influenza in the Asia-Pacific region. Click here for more details. The Lancet *See our Map Of H1N1 Outbreaks *See our Mexico Swine Flu Blog


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009